{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,4]],"date-time":"2026-03-04T19:06:43Z","timestamp":1772651203970,"version":"3.50.1"},"reference-count":52,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2017,5,15]],"date-time":"2017-05-15T00:00:00Z","timestamp":1494806400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2017,5,15]],"date-time":"2017-05-15T00:00:00Z","timestamp":1494806400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Non-alcoholic fatty liver disease (NAFLD) incorporates steatosis, non-alcoholic steato-hepatitis (NASH) and liver cirrhosis, associating with diabetes and cardiovascular disease (CVD). TNF-related apoptosis-inducing ligand (TRAIL) is protective of CVD. We aimed to determine whether TRAIL protects against insulin resistance, NAFLD and vascular injury. Twelve-week high fat diet (HFD)-fed <jats:italic>Trail<\/jats:italic><jats:sup>\u2212<jats:italic>\/<\/jats:italic>\u2212<\/jats:sup> mice had increased plasma cholesterol, insulin and glucose compared to wildtype. Insulin tolerance was impaired with TRAIL-deletion, with reduced p-Akt, GLUT4 expression and glucose uptake in skeletal muscle. Hepatic triglyceride content, inflammation and fibrosis were increased with TRAIL-deletion, with elevated expression of genes regulating lipogenesis and gluconeogenesis. Moreover, <jats:italic>Trail<\/jats:italic><jats:sup>\u2212<jats:italic>\/<\/jats:italic>\u2212<\/jats:sup> mice exhibited reduced aortic vasorelaxation, impaired insulin signaling, and &gt;20-fold increased mRNA expression for IL-1\u03b2, IL-6, and TNF-\u03b1. <jats:italic>In vitro<\/jats:italic>, palmitate treatment of hepatocytes increased lipid accumulation, inflammation and fibrosis, with TRAIL mRNA significantly reduced. TRAIL administration inhibited palmitate-induced hepatocyte lipid uptake. Finally, patients with NASH had significantly reduced plasma TRAIL compared to control, simple steatosis or obese individuals. These findings suggest that TRAIL protects against insulin resistance, NAFLD and vascular inflammation. Increasing TRAIL levels may be an attractive therapeutic strategy, to reduce features of diabetes, as well as liver and vascular injury, so commonly observed in individuals with NAFLD.<\/jats:p>","DOI":"10.1038\/s41598-017-01721-4","type":"journal-article","created":{"date-parts":[[2017,5,9]],"date-time":"2017-05-09T10:22:18Z","timestamp":1494325338000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":39,"title":["Non-alcoholic fatty liver disease, vascular inflammation and insulin resistance are exacerbated by TRAIL deletion in mice"],"prefix":"10.1038","volume":"7","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1723-2679","authenticated-orcid":false,"given":"Si\u00e2n P.","family":"Cartland","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hanis H.","family":"Harith","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Scott W.","family":"Genner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lei","family":"Dang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Victoria C.","family":"Cogger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Melissa","family":"Vellozzi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Belinda A.","family":"Di Bartolo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shane R.","family":"Thomas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Leon A.","family":"Adams","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mary M.","family":"Kavurma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2017,5,15]]},"reference":[{"key":"1721_CR1","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1111\/jgh.13082","volume":"31","author":"J Howell","year":"2016","unstructured":"Howell, J. et al. The increasing burden of potentially preventable liver disease among adult liver transplant recipients: A comparative analysis of liver transplant indication by era in Australia and New Zealand. J Gastroenterol Hepatol \n                           31, 434\u2013441, doi:10.1111\/jgh.13082 (2016).","journal-title":"J Gastroenterol Hepatol"},{"key":"1721_CR2","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1053\/j.gastro.2014.11.039","volume":"148","author":"RJ Wong","year":"2015","unstructured":"Wong, R. J. et al. Nonalcoholic steatohepatitis is the second leading etiology of liver disease among adults awaiting liver transplantation in the United States. Gastroenterology \n                           148, 547\u2013555, doi:10.1053\/j.gastro.2014.11.039 (2015).","journal-title":"Gastroenterology"},{"key":"1721_CR3","doi-asserted-by":"publisher","first-page":"97","DOI":"10.3109\/10408363.2011.596521","volume":"48","author":"BW Smith","year":"2011","unstructured":"Smith, B. W. & Adams, L. A. Non-alcoholic fatty liver disease. Crit Rev Clin Lab Sci \n                           48, 97\u2013113, doi:10.3109\/10408363.2011.596521 (2011).","journal-title":"Crit Rev Clin Lab Sci"},{"key":"1721_CR4","doi-asserted-by":"publisher","first-page":"3617","DOI":"10.1007\/s00018-013-1264-x","volume":"70","author":"NS Azahri","year":"2013","unstructured":"Azahri, N. S. & Kavurma, M. M. Transcriptional regulation of tumour necrosis factor-related apoptosis-inducing ligand. Cellular and molecular life sciences: CMLS \n                           70, 3617\u20133629, doi:10.1007\/s00018-013-1264-x (2013).","journal-title":"Cellular and molecular life sciences: CMLS"},{"key":"1721_CR5","doi-asserted-by":"publisher","first-page":"1441","DOI":"10.1016\/j.bcp.2007.10.020","volume":"75","author":"MM Kavurma","year":"2008","unstructured":"Kavurma, M. M. & Bennett, M. R. Expression, regulation and function of trail in atherosclerosis. Biochem Pharmacol \n                           75, 1441\u20131450, doi:10.1016\/j.bcp.2007.10.020 (2008).","journal-title":"Biochem Pharmacol"},{"key":"1721_CR6","doi-asserted-by":"publisher","first-page":"1694","DOI":"10.1161\/ATVBAHA.107.155143","volume":"28","author":"MM Kavurma","year":"2008","unstructured":"Kavurma, M. M., Tan, N. Y. & Bennett, M. R. Death receptors and their ligands in atherosclerosis. Arterioscler Thromb Vasc Biol \n                           28, 1694\u20131702, doi:10.1161\/ATVBAHA.107.155143 (2008).","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"1721_CR7","doi-asserted-by":"publisher","first-page":"578","DOI":"10.1016\/j.tem.2013.07.001","volume":"24","author":"HH Harith","year":"2013","unstructured":"Harith, H. H., Morris, M. J. & Kavurma, M. M. On the TRAIL of obesity and diabetes. Trends Endocrinol Metab \n                           24, 578\u2013587, doi:10.1016\/j.tem.2013.07.001 (2013).","journal-title":"Trends Endocrinol Metab"},{"key":"1721_CR8","doi-asserted-by":"publisher","first-page":"e84","DOI":"10.1016\/j.diabres.2012.02.028","volume":"96","author":"A Bisgin","year":"2012","unstructured":"Bisgin, A., Yalcin, A. D. & Gorczynski, R. M. Circulating soluble tumor necrosis factor related apoptosis inducing-ligand (TRAIL) is decreased in type-2 newly diagnosed, non-drug using diabetic patients. Diabetes Res Clin Pract \n                           96, e84\u201386, doi:10.1016\/j.diabres.2012.02.028 (2012).","journal-title":"Diabetes Res Clin Pract"},{"key":"1721_CR9","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1016\/j.atherosclerosis.2005.10.028","volume":"184","author":"M Schoppet","year":"2006","unstructured":"Schoppet, M., Sattler, A. M., Schaefer, J. R. & Hofbauer, L. C. Osteoprotegerin (OPG) and tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) levels in atherosclerosis. Atherosclerosis \n                           184, 446\u2013447, doi:10.1016\/j.atherosclerosis.2005.10.028 (2006).","journal-title":"Atherosclerosis"},{"key":"1721_CR10","doi-asserted-by":"publisher","first-page":"3157","DOI":"10.1007\/s00125-011-2308-0","volume":"54","author":"BA Di Bartolo","year":"2011","unstructured":"Di Bartolo, B. A. et al. TNF-related apoptosis-inducing ligand (TRAIL) protects against diabetes and atherosclerosis in Apoe (\u2212\/\u2212) mice. Diabetologia \n                           54, 3157\u20133167, doi:10.1007\/s00125-011-2308-0 (2011).","journal-title":"Diabetologia"},{"key":"1721_CR11","doi-asserted-by":"publisher","first-page":"29965","DOI":"10.1074\/jbc.M110.128694","volume":"285","author":"D Gao","year":"2010","unstructured":"Gao, D. et al. The effects of palmitate on hepatic insulin resistance are mediated by NADPH Oxidase 3-derived reactive oxygen species through JNK and p38MAPK pathways. J Biol Chem \n                           285, 29965\u201329973, doi:10.1074\/jbc.M110.128694 (2010).","journal-title":"J Biol Chem"},{"key":"1721_CR12","doi-asserted-by":"publisher","first-page":"e0155163","DOI":"10.1371\/journal.pone.0155163","volume":"11","author":"VH Fengler","year":"2016","unstructured":"Fengler, V. H. et al. Susceptibility of Different Mouse Wild Type Strains to Develop Diet-Induced NAFLD\/AFLD-Associated Liver Disease. PloS one \n                           11, e0155163, doi:10.1371\/journal.pone.0155163 (2016).","journal-title":"PloS one"},{"key":"1721_CR13","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1016\/S1089-3261(05)70168-9","volume":"5","author":"E Albanis","year":"2001","unstructured":"Albanis, E. & Friedman, S. L. Hepatic fibrosis. Pathogenesis and principles of therapy. Clin Liver Dis \n                           5, 315\u2013334, doi:10.1016\/S1089-3261(05)70168-9 v-vi (2001).","journal-title":"Clin Liver Dis"},{"key":"1721_CR14","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1053\/jhep.2001.21045","volume":"33","author":"A Geerts","year":"2001","unstructured":"Geerts, A. et al. Formation of normal desmin intermediate filaments in mouse hepatic stellate cells requires vimentin. Hepatology \n                           33, 177\u2013188, doi:10.1053\/jhep.2001.21045 (2001).","journal-title":"Hepatology"},{"key":"1721_CR15","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1016\/j.dld.2004.11.009","volume":"37","author":"G Carpino","year":"2005","unstructured":"Carpino, G. et al. Alpha-SMA expression in hepatic stellate cells and quantitative analysis of hepatic fibrosis in cirrhosis and in recurrent chronic hepatitis after liver transplantation. Dig Liver Dis \n                           37, 349\u2013356, doi:10.1016\/j.dld.2004.11.009 (2005).","journal-title":"Dig Liver Dis"},{"key":"1721_CR16","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1002\/hep.22941","volume":"50","author":"GN Ioannou","year":"2009","unstructured":"Ioannou, G. N., Morrow, O. B., Connole, M. L. & Lee, S. P. Association between dietary nutrient composition and the incidence of cirrhosis or liver cancer in the United States population. Hepatology \n                           50, 175\u2013184, doi:10.1002\/hep.22941 (2009).","journal-title":"Hepatology"},{"key":"1721_CR17","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1016\/j.ejphar.2008.01.045","volume":"584","author":"S Zheng","year":"2008","unstructured":"Zheng, S. et al. Ezetimibe improves high fat and cholesterol diet-induced non-alcoholic fatty liver disease in mice. Eur J Pharmacol \n                           584, 118\u2013124, doi:10.1016\/j.ejphar.2008.01.045 (2008).","journal-title":"Eur J Pharmacol"},{"key":"1721_CR18","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1007\/s00251-009-0389-4","volume":"61","author":"X Yan","year":"2009","unstructured":"Yan, X. et al. sTRAIL levels and TRAIL gene polymorphisms in Chinese patients with fatty liver disease. Immunogenetics \n                           61, 551\u2013556, doi:10.1007\/s00251-009-0389-4 (2009).","journal-title":"Immunogenetics"},{"key":"1721_CR19","doi-asserted-by":"publisher","first-page":"1686","DOI":"10.1128\/MCB.01321-14","volume":"35","author":"JI Kim","year":"2015","unstructured":"Kim, J. I. et al. Lipid-overloaded enlarged adipocytes provoke insulin resistance independent of inflammation. Mol Cell Biol \n                           35, 1686\u20131699, doi:10.1128\/MCB.01321-14 (2015).","journal-title":"Mol Cell Biol"},{"key":"1721_CR20","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1016\/j.jacl.2013.04.001","volume":"7","author":"HE Bays","year":"2013","unstructured":"Bays, H. E. et al. Obesity, adiposity, and dyslipidemia: a consensus statement from the National Lipid Association. J Clin Lipidol \n                           7, 304\u2013383, doi:10.1016\/j.jacl.2013.04.001 (2013).","journal-title":"J Clin Lipidol"},{"key":"1721_CR21","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1002\/hep.25789","volume":"57","author":"C Savard","year":"2013","unstructured":"Savard, C. et al. Synergistic interaction of dietary cholesterol and dietary fat in inducing experimental steatohepatitis. Hepatology \n                           57, 81\u201392, doi:10.1002\/hep.25789 (2013).","journal-title":"Hepatology"},{"key":"1721_CR22","doi-asserted-by":"publisher","first-page":"815","DOI":"10.1126\/science.277.5327.815","volume":"277","author":"G Pan","year":"1997","unstructured":"Pan, G. et al. An antagonist decoy receptor and a death domain-containing receptor for TRAIL. Science \n                           277, 815\u2013818, doi:10.1126\/science.277.5327.815 (1997).","journal-title":"Science"},{"key":"1721_CR23","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1038\/75045","volume":"6","author":"M Jo","year":"2000","unstructured":"Jo, M. et al. Apoptosis induced in normal human hepatocytes by tumor necrosis factor-related apoptosis-inducing ligand. Nature medicine \n                           6, 564\u2013567, doi:10.1038\/75045 (2000).","journal-title":"Nature medicine"},{"key":"1721_CR24","doi-asserted-by":"publisher","first-page":"1124","DOI":"10.1136\/gut.2006.118059","volume":"56","author":"H Malhi","year":"2007","unstructured":"Malhi, H., Barreyro, F. J., Isomoto, H., Bronk, S. F. & Gores, G. J. Free fatty acids sensitise hepatocytes to TRAIL mediated cytotoxicity. Gut \n                           56, 1124\u20131131, doi:10.1136\/gut.2006.118059 (2007).","journal-title":"Gut"},{"key":"1721_CR25","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1111\/j.1440-1746.2009.05785.x","volume":"24","author":"GC Farrell","year":"2009","unstructured":"Farrell, G. C. et al. Apoptosis in experimental NASH is associated with p53 activation and TRAIL receptor expression. J Gastroenterol Hepatol \n                           24, 443\u2013452, doi:10.1111\/j.1440-1746.2009.05785.x (2009).","journal-title":"J Gastroenterol Hepatol"},{"key":"1721_CR26","doi-asserted-by":"publisher","first-page":"1156","DOI":"10.1016\/j.jhep.2014.11.033","volume":"62","author":"L Idrissova","year":"2015","unstructured":"Idrissova, L. et al. TRAIL receptor deletion in mice suppresses the inflammation of nutrient excess. J Hepatol \n                           62, 1156\u20131163, doi:10.1016\/j.jhep.2014.11.033 (2015).","journal-title":"J Hepatol"},{"key":"1721_CR27","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1016\/S0016-5085(03)00907-7","volume":"125","author":"AE Feldstein","year":"2003","unstructured":"Feldstein, A. E. et al. Hepatocyte apoptosis and fas expression are prominent features of human nonalcoholic steatohepatitis. Gastroenterology \n                           125, 437\u2013443, doi:10.1016\/S0016-5085(03)00907-7 (2003).","journal-title":"Gastroenterology"},{"key":"1721_CR28","doi-asserted-by":"publisher","first-page":"1641","DOI":"10.1053\/j.gastro.2008.03.002","volume":"134","author":"H Malhi","year":"2008","unstructured":"Malhi, H. & Gores, G. J. Cellular and molecular mechanisms of liver injury. Gastroenterology \n                           134, 1641\u20131654, doi:10.1053\/j.gastro.2008.03.002 (2008).","journal-title":"Gastroenterology"},{"key":"1721_CR29","doi-asserted-by":"publisher","first-page":"S31","DOI":"10.1002\/hep.21062","volume":"43","author":"H Malhi","year":"2006","unstructured":"Malhi, H., Gores, G. J. & Lemasters, J. J. Apoptosis and necrosis in the liver: a tale of two deaths? Hepatology \n                           43, S31\u201344, doi:10.1002\/hep.21062 (2006).","journal-title":"Hepatology"},{"key":"1721_CR30","doi-asserted-by":"publisher","first-page":"4187","DOI":"10.1016\/j.febslet.2010.08.052","volume":"584","author":"S Wueest","year":"2010","unstructured":"Wueest, S., Rapold, R. A., Schoenle, E. J. & Konrad, D. Fas activation in adipocytes impairs insulin-stimulated glucose uptake by reducing Akt. FEBS Lett \n                           584, 4187\u20134192, doi:10.1016\/j.febslet.2010.08.052 (2010).","journal-title":"FEBS Lett"},{"key":"1721_CR31","doi-asserted-by":"publisher","first-page":"39336","DOI":"10.1074\/jbc.M111.280420","volume":"286","author":"SC Cazanave","year":"2011","unstructured":"Cazanave, S. C. et al. Death receptor 5 signaling promotes hepatocyte lipoapoptosis. J Biol Chem \n                           286, 39336\u201339348, doi:10.1074\/jbc.M111.280420 (2011).","journal-title":"J Biol Chem"},{"key":"1721_CR32","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1172\/JCI4765","volume":"103","author":"WA Faubion","year":"1999","unstructured":"Faubion, W. A. et al. Toxic bile salts induce rodent hepatocyte apoptosis via direct activation of Fas. J Clin Invest \n                           103, 137\u2013145, doi:10.1172\/JCI4765 (1999).","journal-title":"J Clin Invest"},{"key":"1721_CR33","doi-asserted-by":"crossref","first-page":"G992","DOI":"10.1152\/ajpgi.2000.278.6.G992","volume":"278","author":"T Sodeman","year":"2000","unstructured":"Sodeman, T., Bronk, S. F., Roberts, P. J., Miyoshi, H. & Gores, G. J. Bile salts mediate hepatocyte apoptosis by increasing cell surface trafficking of Fas. Am J Physiol Gastrointest Liver Physiol \n                           278, G992\u2013999 (2000).","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"1721_CR34","doi-asserted-by":"publisher","first-page":"23301","DOI":"10.1074\/jbc.M200964200","volume":"277","author":"Y Sun","year":"2002","unstructured":"Sun, Y. et al. Phosphoenolpyruvate carboxykinase overexpression selectively attenuates insulin signaling and hepatic insulin sensitivity in transgenic mice. J Biol Chem \n                           277, 23301\u201323307, doi:10.1074\/jbc.M200964200 (2002).","journal-title":"J Biol Chem"},{"key":"1721_CR35","doi-asserted-by":"publisher","first-page":"e210","DOI":"10.1016\/j.clnme.2014.09.004","volume":"9","author":"K Samaras","year":"2014","unstructured":"Samaras, K., Morris, M. J., Lord, R. S. & Kavurma, M. M. The effect of bariatric surgery on serum TRAIL and osteoprotegerin levels in obesity complicated by glucose disorders. eSpen Journal \n                           9, e210\u2013e214, doi:10.1016\/j.clnme.2014.09.004 (2014).","journal-title":"eSpen Journal"},{"key":"1721_CR36","doi-asserted-by":"publisher","first-page":"E36","DOI":"10.1210\/jc.2013-2488","volume":"99","author":"M Bluher","year":"2014","unstructured":"Bluher, M. et al. Fas and FasL expression in human adipose tissue is related to obesity, insulin resistance, and type 2 diabetes. J Clin Endocrinol Metab \n                           99, E36\u201344, doi:10.1210\/jc.2013-2488 (2014).","journal-title":"J Clin Endocrinol Metab"},{"key":"1721_CR37","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1055\/s-0029-1212086","volume":"107","author":"GS Hotamisligil","year":"1999","unstructured":"Hotamisligil, G. S. Mechanisms of TNF-alpha-induced insulin resistance. Experimental and clinical endocrinology & diabetes: official journal, German Society of Endocrinology [and] German Diabetes Association \n                           107, 119\u2013125, doi:10.1055\/s-0029-1212086 (1999).","journal-title":"Experimental and clinical endocrinology & diabetes: official journal, German Society of Endocrinology [and] German Diabetes Association"},{"key":"1721_CR38","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1007\/s11906-009-0010-0","volume":"11","author":"IH Schulman","year":"2009","unstructured":"Schulman, I. H. & Zhou, M. S. Vascular insulin resistance: a potential link between cardiovascular and metabolic diseases. Curr Hypertens Rep \n                           11, 48\u201355, doi:10.1007\/s11906-009-0010-0 (2009).","journal-title":"Curr Hypertens Rep"},{"key":"1721_CR39","doi-asserted-by":"publisher","first-page":"1793","DOI":"10.1172\/JCI29069","volume":"116","author":"SE Shoelson","year":"2006","unstructured":"Shoelson, S. E., Lee, J. & Goldfine, A. B. Inflammation and insulin resistance. J Clin Invest \n                           116, 1793\u20131801, doi:10.1172\/JCI29069 (2006).","journal-title":"J Clin Invest"},{"key":"1721_CR40","doi-asserted-by":"publisher","first-page":"2596","DOI":"10.1093\/ndt\/gfq042","volume":"25","author":"S Liabeuf","year":"2010","unstructured":"Liabeuf, S. et al. The circulating soluble TRAIL is a negative marker for inflammation inversely associated with the mortality risk in chronic kidney disease patients. Nephrology, dialysis, transplantation: official publication of the European Dialysis and Transplant Association - European Renal Association \n                           25, 2596\u20132602, doi:10.1093\/ndt\/gfq042 (2010).","journal-title":"Nephrology, dialysis, transplantation: official publication of the European Dialysis and Transplant Association - European Renal Association"},{"key":"1721_CR41","doi-asserted-by":"publisher","first-page":"904","DOI":"10.1681\/ASN.2007050581","volume":"19","author":"C Lorz","year":"2008","unstructured":"Lorz, C. et al. The death ligand TRAIL in diabetic nephropathy. J Am Soc Nephrol \n                           19, 904\u2013914, doi:10.1681\/ASN.2007050581 (2008).","journal-title":"J Am Soc Nephrol"},{"key":"1721_CR42","doi-asserted-by":"publisher","first-page":"e92952","DOI":"10.1371\/journal.pone.0092952","volume":"9","author":"SP Cartland","year":"2014","unstructured":"Cartland, S. P., Erlich, J. H. & Kavurma, M. M. TRAIL deficiency contributes to diabetic nephropathy in fat-fed ApoE\u2212\/\u2212 mice. PloS one \n                           9, e92952, doi:10.1371\/journal.pone.0092952 (2014).","journal-title":"PloS one"},{"key":"1721_CR43","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1042\/CS20120176","volume":"123","author":"S Bernardi","year":"2012","unstructured":"Bernardi, S. et al. TNF-related apoptosis-inducing ligand significantly attenuates metabolic abnormalities in high-fat-fed mice reducing adiposity and systemic inflammation. Clin Sci (Lond) \n                           123, 547\u2013555, doi:10.1042\/CS20120176 (2012).","journal-title":"Clin Sci (Lond)"},{"key":"1721_CR44","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1111\/imj.12936","volume":"46","author":"P Pateria","year":"2016","unstructured":"Pateria, P. et al. The association between chronic hepatitis C infection and cardiovascular risk. Internal medicine journal \n                           46, 63\u201370, doi:10.1111\/imj.12936 (2016).","journal-title":"Internal medicine journal"},{"key":"1721_CR45","doi-asserted-by":"publisher","first-page":"1313","DOI":"10.1002\/hep.20701","volume":"41","author":"DE Kleiner","year":"2005","unstructured":"Kleiner, D. E. et al. Design and validation of a histological scoring system for nonalcoholic fatty liver disease. Hepatology \n                           41, 1313\u20131321, doi:10.1002\/hep.20701 (2005).","journal-title":"Hepatology"},{"key":"1721_CR46","doi-asserted-by":"publisher","first-page":"1222","DOI":"10.1128\/MCB.01035-15","volume":"36","author":"JA Thoms","year":"2016","unstructured":"Thoms, J. A. et al. Arrested Hematopoiesis and Vascular Relaxation Defects in Mice with a Mutation in Dhfr. Mol Cell Biol \n                           36, 1222\u20131236, doi:10.1128\/MCB.01035-15 (2016).","journal-title":"Mol Cell Biol"},{"key":"1721_CR47","doi-asserted-by":"publisher","first-page":"444","DOI":"10.2337\/db12-0244","volume":"62","author":"X Wang","year":"2013","unstructured":"Wang, X. et al. PAQR3 modulates insulin signaling by shunting phosphoinositide 3-kinase p110alpha to the Golgi apparatus. Diabetes \n                           62, 444\u2013456, doi:10.2337\/db12-0244 (2013).","journal-title":"Diabetes"},{"key":"1721_CR48","doi-asserted-by":"publisher","first-page":"439835","DOI":"10.1155\/2011\/439835","volume":"2011","author":"A Warren","year":"2011","unstructured":"Warren, A. et al. The effects of old age on hepatic stellate cells. Curr Gerontol Geriatr Res \n                           2011, 439835\u20137, doi:10.1155\/2011\/439835 (2011).","journal-title":"Curr Gerontol Geriatr Res"},{"key":"1721_CR49","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1194\/jlr.M043281","volume":"55","author":"KC McGrath","year":"2014","unstructured":"McGrath, K. C. et al. High density lipoproteins improve insulin sensitivity in high-fat diet-fed mice by suppressing hepatic inflammation. J Lipid Res \n                           55, 421\u2013430, doi:10.1194\/jlr.M043281 (2014).","journal-title":"J Lipid Res"},{"key":"1721_CR50","doi-asserted-by":"publisher","first-page":"e74211","DOI":"10.1371\/journal.pone.0074211","volume":"8","author":"BA Di Bartolo","year":"2013","unstructured":"Di Bartolo, B. A. et al. TRAIL-Deficiency Accelerates Vascular Calcification in Atherosclerosis via Modulation of RANKL. PloS one \n                           8, e74211, doi:10.1371\/journal.pone.0074211 (2013).","journal-title":"PloS one"},{"key":"1721_CR51","doi-asserted-by":"publisher","first-page":"e002527","DOI":"10.1161\/JAHA.115.002527","volume":"4","author":"BA Di Bartolo","year":"2015","unstructured":"Di Bartolo, B. A. et al. Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand (TRAIL) Promotes Angiogenesis and Ischemia-Induced Neovascularization Via NADPH Oxidase 4 (NOX4) and Nitric Oxide-Dependent Mechanisms. Journal of the American Heart Association \n                           4, e002527\u2013e002527, doi:10.1161\/JAHA.115.002527 (2015).","journal-title":"Journal of the American Heart Association"},{"key":"1721_CR52","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1677\/jme.0.0250169","volume":"25","author":"SA Bustin","year":"2000","unstructured":"Bustin, S. A. Absolute quantification of mRNA using real-time reverse transcription polymerase chain reaction assays. Journal of molecular endocrinology \n                           25, 169\u2013193, doi:10.1677\/jme.0.0250169 (2000).","journal-title":"Journal of molecular endocrinology"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-017-01721-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-017-01721-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-017-01721-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,23]],"date-time":"2022-12-23T04:18:31Z","timestamp":1671769111000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-017-01721-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,5,15]]},"references-count":52,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2017,12]]}},"alternative-id":["1721"],"URL":"https:\/\/doi.org\/10.1038\/s41598-017-01721-4","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,5,15]]},"assertion":[{"value":"20 September 2016","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 March 2017","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 May 2017","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare that they have no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}],"article-number":"1898"}}